A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma Patients.
Hum Gene Ther
; 30(3): 352-364, 2019 03.
Article
in En
| MEDLINE
| ID: mdl-30234393
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Genetic Therapy
/
Adenoviridae
/
Oncolytic Viruses
/
Oncolytic Virotherapy
/
Genetic Vectors
/
Melanoma
Type of study:
Diagnostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Hum Gene Ther
Journal subject:
GENETICA MEDICA
/
TERAPEUTICA
Year:
2019
Document type:
Article
Affiliation country: